https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3AGLP1_poly-agonist_peptides%2F1%2FenTranslations:GLP1 poly-agonist peptides/1/en - Revision history2026-08-25T01:07:21ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:GLP1_poly-agonist_peptides/1/en&diff=133031&oldid=prevFuzzyBot: Importing a new version from external source2024-04-02T13:01:47Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>'''GLP1 poly-agonist peptides''' are a class of drugs that activate multiple [[peptide hormone]] receptors including the [[glucagon-like peptide-1 receptor|glucagon-like peptide-1 (GLP-1) receptor]]. These drugs are developed for the same indications as [[GLP-1 receptor agonist]]s—especially obesity, type 2 diabetes, and non-alcoholic fatty liver disease. They are expected to provide superior efficacy with fewer adverse effects compared to GLP-1 mono-agonists, which are dose-limited by gastrointestinal disturbances. The effectiveness of multi-receptor agonists could possibly equal or exceed that of [[bariatric surgery]]. The first such drug to receive approval is [[tirzepatide]], a dual agonist of GLP-1 and [[GIP receptor]]s.</div>FuzzyBot